Discuss the indications, operative steps and complications of laparoscopic TEP repair for inguinal herni
laparoscopic TEP repair inguinal hernia indications operative steps complications
| Trocar | Size | Position |
|---|---|---|
| Camera port (T1) | 10-12 mm | Infraumbilical midline, just below umbilicus |
| Working port (T2) | 5 mm | Midline, midway between umbilicus and pubis |
| Working port (T3) | 5 mm | Midline, just above pubic symphysis |
| Complication | Notes |
|---|---|
| Peritoneal tear | Most common intraoperative problem; small tears can be managed with clips; large tears may require conversion to TAPP or open; CO₂ leak into peritoneum collapses the working space |
| Vascular injury - inferior epigastric vessels | Most common vascular injury; occurs during trocar insertion or lateral dissection; usually controlled with diathermy or suture ligation |
| Vascular injury - iliac vessels/corona mortis | Potentially life-threatening; corona mortis (aberrant obturator artery from inferior epigastric) is at risk on Cooper's ligament; requires immediate control |
| Bladder injury | Occurs if bladder not decompressed and dissection is too medial in the Space of Retzius; recognized by pneumaturia or visible opening; requires repair |
| Bowel injury | Rare with TEP (advantage over TAPP); can occur with sharp dissection near peritoneal tears |
| Vas deferens injury | Can occur during cord skeletonization - irreversible; leads to infertility in males with bilateral injury |
| Conversion to open | Rate approximately 2-5%; indications: dense adhesions, uncontrolled bleeding, large peritoneal tears |
| Complication | Incidence | Notes |
|---|---|---|
| Seroma | 4-8% (most common) | More common after large direct hernias; usually self-limiting; avoid aspiration unless symptomatic; resolves over weeks |
| Urinary retention | 3-5% | Due to Trendelenburg position, general anesthesia, pelvic dissection; catheterization usually resolves it |
| Rectus sheath hematoma | ~1.4% | From trocar insertion or injury to inferior epigastric vessels |
| Scrotal hematoma/ecchymosis | More common after large indirect sacs; bruising tracked along spermatic cord | |
| Wound infection | <1% | Lower than open repair; mesh infection is rare |
| Acute testicular pain | Related to handling of cord structures | |
| Trocar site hernia | Rare; umbilical fascial defect should be closed |
| Complication | Details |
|---|---|
| Chronic post-operative inguinal pain (CPIP) | Clinically significant CPIP in up to 12% overall; disabling daily pain 0.5-6%; LOWER with laparoscopic vs open repair; mechanism: nerve entrapment (ilioinguinal nerve not at risk in TEP as it is in open), tack fixation injury (lateral femoral cutaneous nerve, genitofemoral nerve), mesh contraction |
| Recurrence | 0.5-3%; causes include inadequate mesh size, mesh migration/folding, missed hernia defect (especially femoral), technical error, failure of fixation in large direct hernias |
| Testicular atrophy/ischemia | Rare (<0.5%); due to injury to testicular vessels during cord skeletonization |
| Mesh-related complications | Mesh infection (<0.1%); mesh migration; mesh shrinkage/contraction causing chronic pain; mesh erosion into adjacent structures (rare) |
| Sexual dysfunction/dysejaculation | Due to sympathetic plexus injury around vas deferens; ejaculatory pain |
| Osteitis pubis | Rare; from periosteal reaction at pubic symphysis fixation point |
| Adhesion/bowel obstruction | Very rare with TEP (significant advantage over TAPP); can occur with large peritoneal rents |
| Feature | TEP | TAPP |
|---|---|---|
| Peritoneal entry | No | Yes |
| Bowel injury risk | Lower | Higher |
| Adhesion risk | Very low | Higher |
| Peritoneal closure | Not required | Required |
| Learning curve | Steeper | Less steep |
| Prior pelvic surgery | Difficult | Better access |
| Bilateral hernias | Both can be done | Both can be done |
| Conversion option | Can convert to TAPP | Can convert to open |
| General anesthesia | Required | Required |
Recent advances in management of large incisional hernia.
incisional hernia repair advances
recent advances large incisional hernia management 2023 2024 2025 robotic component separation biologic mesh
transversus abdominis release TAR hernia abdominal wall reconstruction
PMID: 37329437
PMID: 39528659
PMID: 40360803
PMID: 38319440
PMID: 38632220
| Outcome | rTAR | oTAR | p-value |
|---|---|---|---|
| Overall complications | 9% | 24.6% | <0.01 |
| Intraoperative complications | 5.9% | 9.1% | 0.02 |
| SSI | 2.5% | 7.8% | 0.01 |
| Fascial closure | 99% | 94.6% | 0.11 (NS) |
| Operative time | Longer | Shorter | <0.001 |
| Length of stay | -3.9 days shorter | Reference | <0.05 |
| Mesh Position | Approach | Recurrence | SSO | Use in Large Defects |
|---|---|---|---|---|
| Bridging (inlay) | Open | Highest (50%+) | High | Only when fascia cannot be closed |
| Onlay | Open | High (10-20%) | High (skin necrosis, seroma) | Limited role |
| Retromuscular (Rives-Stoppa) | Open/Robotic | Low (4-10%) | Moderate | Gold standard for medium-large |
| Retromuscular + TAR | Open/Robotic | Low | Low (with robotic) | Gold standard for large/complex |
| IPOM-plus | Laparoscopic | Low-moderate | Moderate | Medium defects; less ideal for large |
| Advance | Clinical Impact |
|---|---|
| Botulinum Toxin A preop | Stretches lateral muscles ~4 cm per side; enables fascial closure without or with lesser component separation |
| TAR (Posterior CS) | Lower SSO than anterior CS; enables large retromuscular space for mesh; preferred for large defects |
| Robotic TAR (rTAR) | Minimally invasive posterior CS; lower SSI and complications vs open; longer OR time; similar recurrence |
| eTEP approach | Fully extraperitoneal laparoscopic/robotic repair; avoids adhesiolysis; no anti-adhesion mesh needed |
| IPOM-Plus | Fascial closure during IPOM halves recurrence risk and seroma formation vs IPOM alone |
| Biosynthetic mesh | Slowly absorbable option for contaminated fields; emerging alternative to costly biologic mesh |
| 3D-printed mesh | Investigational; patient-specific geometry; limited evidence |
| NPWT/VAC | Wound management tool reducing SSI in contaminated repairs; mesh salvage protocol |
| ICAP classification | Standardized mesh plane terminology enabling consistent research and communication |
| Prehabilitation programs | Modifiable risk factor optimization reducing wound complications |
Describe the surgical anatomy of the anterior abdominal wall. Briefly discuss its importance in management of ventral hernia repair
surgical anatomy anterior abdominal wall layers muscles fascia nerves blood supply ventral hernia repair importance
| Layer | Notes |
|---|---|
| 1. Skin | Freely mobile over most of the wall |
| 2. Subcutaneous tissue | Variable thickness based on body habitus |
| 3. Superficial fascia (Camper's + Scarpa's) | Superficial fatty layer (Camper's); deep membranous layer (Scarpa's) below umbilicus |
| 4. External oblique muscle/aponeurosis | |
| 5. Internal oblique muscle/aponeurosis | |
| 6. Transversus abdominis muscle/aponeurosis | |
| 7. Transversalis fascia | Thin but important fibrous layer |
| 8. Preperitoneal adipose and areolar tissue | Contains the preperitoneal space |
| 9. Peritoneum | Innermost layer |



| Space / Plane | Location | Clinical Use |
|---|---|---|
| Subcutaneous plane | Between skin and anterior rectus sheath | Onlay mesh placement |
| Premusculofascial (subaponeurotic) plane | Between EO aponeurosis and IO | Minimally invasive anterior CS (EOR) |
| Retrorectus (Rives-Stoppa) space | Between rectus muscle and posterior rectus sheath | Gold standard sublay mesh position |
| TAR space | Between TA muscle and transversalis fascia, posterior to posterior sheath | TAR for large hernias; extends mesh overlap further laterally |
| Preperitoneal space | Between transversalis fascia and peritoneum | TAPP, TEP, eTEP hernia repair |
| Intraperitoneal space | Inside peritoneal cavity | IPOM repair |
| Site | Anatomical Basis | Hernia Type |
|---|---|---|
| Umbilicus | Convergence of all layers; obliterated umbilical structures | Umbilical hernia |
| Linea alba | Decussating aponeurotic fibers; wider above umbilicus | Epigastric hernia |
| Surgical incisions | Failed fascial healing; collagen defects | Incisional hernia |
| Deep inguinal ring | Lateral inguinal fossa; weakness in TA fascia | Indirect inguinal hernia |
| Hesselbach's triangle | Medial inguinal fossa; behind posterior inguinal wall | Direct inguinal hernia |
| Femoral ring | Below inguinal ligament, medial to femoral vein | Femoral hernia |
| Linea semilunaris | Junction of aponeuroses at lateral rectus sheath | Spigelian hernia |
| Obturator foramen | Obturator membrane defect | Obturator hernia |
| Lumbar triangles | Superior (Grynfeltt) and inferior (Petit) | Lumbar hernia |
| Anatomical Feature | Surgical Relevance in Ventral Hernia Repair |
|---|---|
| Linea alba | Primary structure repaired; wider above umbilicus explains epigastric hernias |
| Arcuate line | Defines extent of retrorectus space; mesh plane changes below it |
| Linea semilunaris | Lateral limit of retrorectus dissection; nerve entry point; Spigelian hernia site |
| Posterior rectus sheath | Creates retrorectus space for ideal mesh placement (Rives-Stoppa) |
| TA muscle plane | Divided in TAR to access preperitoneal space; key to large hernia repair |
| Transversalis fascia | Posterior barrier in preperitoneal space; exploited in TEP/eTEP |
| TAP (TA-IO plane) | Route of neurovascular bundles; plane for TAP block |
| DIEA | Landmark for inferior epigastric vessel preservation; basis for DIEP flap |
| SEA-DIEA anastomosis | Zone I perforators underlie rectus musculocutaneous flaps |
| Peritoneal folds | Identify hernia fossae; guide laparoscopic landmark recognition |
| Scarpa's fascia | May limit urinary extravasation spread; closed separately in lower abdomen wounds |
Enumerate the factors responsible for incisional hernias
factors responsible for incisional hernia patient surgical technical risk factors 2024
incisional hernia risk factors etiology systematic review
PMID: 38519402
PMID: 36102959
| Category | Factor | Mechanism |
|---|---|---|
| Patient | Obesity | ↑ IAP, poor tissue perfusion, technical difficulty |
| Patient | Diabetes | Impaired collagen synthesis, ↑ SSI risk |
| Patient | Smoking | Vasoconstriction, ↑ MMPs, ↓ collagen synthesis |
| Patient | Malnutrition | Inadequate collagen substrate |
| Patient | Steroids/immunosuppression | Impairs all phases of wound healing |
| Patient | Collagen disorders | Reduced type I:III ratio; elevated MMP-2 |
| Patient | COPD/chronic cough | Repeatedly elevated IAP |
| Patient | Advanced age | Reduced collagen quality and healing capacity |
| Patient | Previous surgery/radiation | Scarred, poorly vascularised tissue |
| Operative | Midline incision | Poor blood supply; widest zone of linea alba |
| Operative | Large bite suture | Ischaemia of incorporated fat/muscle → suture slack → fascial gap |
| Operative | Low SL:WL ratio (<4:1) | Excessive suture tension → necrosis |
| Operative | Rapidly absorbable suture | Loses strength before fascial healing is adequate |
| Operative | Emergency surgery | No optimisation; contamination; high IAP |
| Operative | Contaminated wound | SSI risk; mesh avoidance |
| Operative | Prolonged operation | Oedema, blood loss, SSI |
| Postoperative | SSI | Protease degradation of forming collagen |
| Postoperative | Wound dehiscence | Direct fascial defect |
| Postoperative | Seroma/haematoma | Infection risk; dead space |
| Postoperative | Ileus/distension | Elevated IAP on fresh closure |
Discuss the methods used for abdominal wall repair
methods abdominal wall repair ventral hernia open laparoscopic robotic mesh techniques 2024 2025
ventral hernia repair laparoscopic open retromuscular mesh comparison outcomes

| ICAP Plane | Location | Synonyms |
|---|---|---|
| Onlay | Anterior to anterior rectus sheath | Supraaponeurotic |
| Inlay | Within defect as bridge | Bridging, interposition |
| Sublay - Retrorectus | Posterior to rectus, anterior to posterior sheath | Rives-Stoppa plane |
| Sublay - Retromuscular | Posterior to TA muscle, anterior to transversalis fascia | TAR space |
| Sublay - Preperitoneal | Between transversalis fascia and peritoneum | Preperitoneal |
| Intraperitoneal | Inside the peritoneal cavity | IPOM |
| Outcome | rTAR | Open TAR | p |
|---|---|---|---|
| Overall complications | 9% | 24.6% | <0.01 |
| SSI | 2.5% | 7.8% | 0.01 |
| Length of stay | -3.9 days shorter | Reference | <0.05 |
| Operative time | Longer | Shorter | <0.001 |
| Fascial closure rate | 99% | 94.6% | NS |
| Defect Size | Preferred Method |
|---|---|
| <2 cm (small) | Primary suture (small-bite technique) ± mesh in high-risk patients |
| 2-4 cm (small-medium) | Mesh repair: retrorectus (Rives-Stoppa) or laparoscopic IPOM-plus |
| 4-10 cm (medium) | Open retrorectus (Rives-Stoppa) or laparoscopic/robotic eTEP-RS |
| >10 cm (large) | TAR (open or robotic) + retromuscular mesh; consider BTA preoperatively |
| Loss of domain | Preoperative optimisation (BTA ± PPP); TAR + large mesh; staged approach |
| Contaminated field | Biologic or biosynthetic mesh; staged repair |
| Emergency/strangulated | Primary repair or absorbable bridging mesh; definitive staged repair |
| Method | Recurrence | SSO/SSI | Advantages | Disadvantages |
|---|---|---|---|---|
| Primary suture | 10-50% (size-dependent) | Low | No mesh | High recurrence for >2 cm |
| Onlay mesh | 10-20% | High (skin flaps) | Simple, no peritoneal entry | Wound complications, subcutaneous mesh |
| Retrorectus (Rives-Stoppa) | 4-10% | Moderate | Gold standard; best integration | Open only; limited to ~8-10 cm defects |
| Open ACS + mesh | 5-15% | High (wound complications) | Large defects | 50% SSO with skin flaps |
| Open TAR + mesh | 5-12% | Moderate (lower than ACS) | Best for large defects | Complex; long OR time |
| Laparoscopic IPOM-plus | 5-15% | Low | MIS; fast recovery | Mesh inside peritoneum; tack pain |
| Robotic eTEP/TAR | 4-10% | Low (SSI 2.5%) | MIS + retromuscular; shorter LOS | Very expensive; longer OR time |
Biological meshes.
biologic mesh hernia repair outcomes contaminated
biological mesh hernia repair types properties indications outcomes 2024 2025
PMID: 35044431
PMID: 39666204
PMID: 36623959
PMID: 40473948
| Source | Tissue | Commercial Examples |
|---|---|---|
| Human (Allograft) | Acellular dermal matrix | AlloDerm (Lifecell), AlloMax, FlexHD |
| Porcine (Xenograft) | Dermis | Strattice (Lifecell), Permacol (Medtronic), CollaMend |
| Porcine (Xenograft) | Small intestinal submucosa (SIS) | Surgisis (Cook Biotech) |
| Porcine (Xenograft) | Urinary bladder matrix | MatriStem |
| Bovine (Xenograft) | Pericardium | Tutomesh, Veritas |
| Bovine (Xenograft) | Dermis | SurgiMend, PeriGuard |
| Fetal bovine | Dermis | SurgiMend PRS |
| Property | Non-Cross-Linked | Cross-Linked |
|---|---|---|
| Tissue remodelling | More extensive; faster incorporation | Less remodelling; slower degradation |
| Strength | Less initial mechanical strength | Greater initial strength |
| Degradation | Faster; risk of premature failure | Slower; more durable long term |
| Host cell infiltration | Better | Reduced |
| Infection resistance | Better (pores allow macrophage access) | Reduced (barrier to immune cells) |
| Examples | AlloDerm, AlloMax, Surgisis, SurgiMend | Permacol (glutaraldehyde cross-linked), CollaMend |
| Product | Material | Degradation time | Use |
|---|---|---|---|
| Phasix (BD) | Poly-4-hydroxybutyrate (P4HB) | 12-18 months | Contaminated fields; high-risk |
| GORE BIO-A | Polyglycolide-trimethylene carbonate | ~6 months | Contaminated repair |
| Vicryl mesh (Ethicon) | Polyglactin 910 | 2-3 months (rapidly absorbed) | Temporary bridge only |
| TIGR matrix | Lactide + glycolide + trimethylene carbonate | 3 years | Long-lasting resorbable reinforcement |
| Outcome | Synthetic Mesh | Biologic Mesh | p-value |
|---|---|---|---|
| 2-year hernia recurrence | 5.6% | 20.5% | <0.001 |
| Surgical site occurrence (SSI/wound complication) | Similar | Similar | 0.58 (NS) |
| Median prosthetic cost | $105 | $21,539 | <0.001 |
| Median 30-day hospital direct cost | $17,289 | $44,936 | <0.001 |
| Complication | Notes |
|---|---|
| High recurrence rate | 20-40% at 2-5 years in contaminated cases; driven by insufficient remodelling and mesh degradation before adequate host tissue formation |
| Seroma | Common; fluid accumulation around degrading scaffold |
| Mesh laxity / bulge | As the mesh degrades before complete replacement by host tissue; leads to functional failure without frank recurrence |
| Infection | Surprisingly not reliably lower than synthetic in recent RCTs; cross-linked meshes may be particularly susceptible |
| Mesh removal | When infected or failed; removal is simpler than synthetic mesh explantation |
| Fistula formation | Particularly hiatal repair; mesh erosion into oesophagus or stomach reported |
| Encapsulation (cross-linked) | Cross-linked mesh may not fully incorporate → persistent foreign body disc |
| High cost | $20,000-$50,000 per case vs. <$200 for synthetic; unsustainable if outcomes are not superior |
| Situation | Current Recommendation |
|---|---|
| Clean field (CDC Class I), elective repair | Synthetic mesh; no role for biologic |
| Clean-contaminated (CDC Class II), elective | Synthetic mesh preferred (retromuscular); biologic no longer first choice |
| Contaminated (CDC Class III) | Synthetic mesh or biosynthetic; biologic only if patient-specific factors strongly favour it |
| Dirty/infected (CDC Class IV) | Biosynthetic (Phasix) or primary repair as staged approach; OR biologic if concurrent infection requires mesh and patient cannot tolerate staged repair |
| Infected mesh explantation | Staged approach preferred; if single-stage needed, retromuscular synthetic or biologic acceptable |
| Transplant/heavy immunosuppression | Biologic remains an option; evidence limited |
| Hiatal hernia reinforcement | Biologic has level I evidence (Oelschlager RCT) for reducing recurrence; but long-term erosion risk limits enthusiasm |